Biermann, who has conducted research on GLP-1 dose frequency, discussed his findings with CBS News Sunday Morning and Business Insider
After behavioral and molecular tests, experimental findings include: Cognitive improvement reduced oxidative stress Alleviation of burden tau proteins and amyloid plaques Observational Studies: These highlighted a 0.20% incidence rate in GLP-1 users compared to 0.44% in non-users, showing a lower dementia risk in patients with type 2 diabetes mellitus and obesity after treatment
Ordering a burger or chicken sandwich wrapped in lettuce instead of a bun may cut down on refined carbs, but keep in mind many of these meals are still high in sodium and saturated fat and low in fiber
In fact, there are even side hustles that could help you lose weight while earning extra spending money
If successful, this could challenge existing oral GLP-1 offerings and expand patient choice by eliminating injections
Antidiabetic drugs for the risk of Alzheimer disease in patients with type 2 DM using FAERS